WHAT IS A biosimilar?
Let’s learn more about what biosimilars are and the process for developing them
WHAT DO biosimilars MEAN for ME?
Let’s explore how biosimilars may potentially expand treatment options to meet the growing demand for biologic therapies
WHAT iS Pfizer’s ROLE?
Let’s learn more about how Pfizer builds on its experience with biologics through Pfizer Biosimilars
biosimilars by the Numbers
Over 100 biologic products will lose patent or other protections by 2022More
Amount of possible savings 11 likeliest biosimilars could create between 2014 and 2024 in the USMore
Pfizer has nearly 10 years of biosimilars experience outside the USMore